vorasidenib
agios pharma,servier
['vorasidenib', 'indigo', 'servier', '$agio']
servier's vorasidenib shows good efficacy in glioma, but 2 cases of hy's law could be a concern for fda review. our take on indigo with -&gt; #asco23 $agio
Once had a blue tick. Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.